Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT).

Trial Profile

Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT).

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Amiodarone (Primary) ; Lidocaine (Primary)
  • Indications Heart arrest; Ventricular fibrillation; Ventricular tachycardia
  • Focus Therapeutic Use
  • Acronyms ALPS
  • Most Recent Events

    • 29 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 04 Apr 2016 Results published in the New England Journal of Medicine
    • 04 Apr 2016 Primary endpoint (Survival to hospital discharge) has not been met, as per the results published in the New England Journal of Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top